Wednesday, 28 October 2020

Vaccination Opposition

The WHO Collaborating Centre on Global Health Histories, which is supported by the Wellcome Trust, has produced a series of seminars in association with the WHO HQ, WHO Regional Offices, WHO Country Offices and national governments, which look at the reasons why a growing number of people are not taking up vaccinations – and how this can be countered. 

 

The seminars can be viewed and/or listened to here: 


Global Health Histories Seminar 107: Cultural contexts of health: vaccine hesitancy - Why do some people not vaccinate?,  WHO Regional Office for Europe, Copenhagen, Denmark

Speakers: Heidi Larson (London School of Hygiene & Tropical Medicine), Robb Butler (WHO Regional Office for Europe)

 

Global Health Histories Seminar 113: Immunization for Universal Health Coverage, Nazarbayev University, Kazakhstan

Speakers; Professor Clare Griffin (School of Humanities and Social Sciences, Nazarbayev University), Dr Byron Crape, Nazarbayev University, Dr Namrata Ganneri (University of York and SNDT College of Arts & SCB College of Commerce and Science for Women, Mumbai).

 

Global Health Histories Seminar 133: The Health Challenges of Social Marginalisation, Timisoara Science Festival, Romania

Speakers: Vlad Mixich (Executive Director of the Romanian Health Observatory and Board Member of the European Public Health Alliance); Lynda Dunlop (Lecturer in the Department of Education at the University of York) Oana Romocea (Executive Director, Hategan Foundation & Founder of the Timisoara Science Festival) and Ruxandra Eva Ciucur (Partner at Hategan Attorneys)

 

This briefing draws upon the presentations at these seminars.

 

In 2020, the hope of a vaccine to target COVID-19 has become a major global focus. Yet there remains a significant minority of people who are not sure if they would accept vaccination – and a number who would flat-out refuse it.

 

“Vaccination is very important. Without it, we wouldn’t have achieved the eradication of smallpox,” says Professor Sanjoy Bhattacharya, director of the Centre for Global Health Histories at the University of York and of the WHO Collaborating Centre for Global Health Histories. Other diseases have been minimised to the point where family doctors often never come across them, and babies in many countries are immunised routinely and repeatedly from the age of a few weeks. Yet the opposition to a COVID-19 vaccine is only part of a greater phenomenon.

 

Opposition to vaccination, or ‘vaccine hesitancy’, is actually increasing in the 21st century. A relatively small number of people are adamantly opposed to all vaccines but a growing number, particularly parents of young children, are sceptical about vaccination or about specific vaccines. “In contrast to the great successes of the 20th century, there have been well-publicised problems with immunisation in the 21st century,” Dr Clare Griffin of Nazarbayev University points out. “The history of vaccination and immunisation is not a march of progress but actually more like a bell curve.” 

 

“The World Health Organization (WHO) estimates that the measles vaccine saved an estimated 17.1 million lives between 2000 and 2015 alone,” says Dr Byron Crape of Nazarbayev University. By contrast, children who have not been vaccinated have been subject to successive outbreaks of measles, pertussis and other diseases, some of which have had serious effects including fatalities. “Every time we have an effective antivaccination movement we see a decline in vaccinations and an increase in the diseases those vaccinations were designed to protect against,” Crape adds.

 

What is fuelling this vaccine hesitancy and the resulting rise in entirely preventable diseases?

 

A movement with a long history


Although the anti-vaccination movement has gained particular traction in recent years, it has been around as long as vaccination itself. “The notion that vaccination is a delusion goes way back, from the moment the whole concepts of vaccination and immunisation were being configured,” says Professor Heidi Larson of the London School of Hygiene & Tropical Medicine, who is also the director of The Vaccine Confidence Project. 

 

The arguments against vaccination have always invoked concepts of ‘purity’ and ‘nature’. “The idea that ‘anything that's natural is better than a vaccine’: that's been around since day one.” And it has, today, become big business too, she adds. “A lot of the naturopathy and homoeopathy books, videos and businesses are making a lot of money promoting their products over-vaccination.” Alongside that, Larson points out, people do not like the idea that vaccination is being imposed on them and/or their children. “The first anti-vaccination leagues were actually initially anti compulsory vaccination.” 

 

The paradox of low-level disease rates


Ironically, the very fact that many diseases are now seen much less frequently has contributed to the drop-in vaccination rates. “When there was a spike in smallpox rates, people got scared and were vaccinated: when rates dropped, demand reduced,” says Bhattacharya. If that is the case with a lethal, much-feared disease it is hardly surprising that it’s the same with other conditions. “If you’ve never seen a vaccine-preventable disease in your community you are less likely to be concerned about that disease. You become complacent and apathy sets in. I'm sure that if I went to my mother's home community on the Isle of Man and I asked people about measles today, half of that community would probably tell me that measles was eliminated decades ago,” says Robb Butler, then WHO 

Programme Manager, Vaccine-preventable Diseases and Immunization and now Executive Director, WHO Regional Office for Europe. “Particularly if you’ve got a concern about vaccination – even if it’s only a very small concern – if you don’t feel you need it, why would you do it?” 

 

That complacency can extend to health policy as a whole, Butler adds. “Fewer and fewer new GPs know what a case of rubella or measles actually looks like. Particularly in countries that have not been witnessed or suffered the phenomenal health and financial costs of an explosively large outbreak, there’s less likely to be sufficient investment in that element of the health programme.”  

 

Dr Vlad Mixich, executive director of the Romanian Health Observatory, explains how measles vaccination rates have dropped dramatically in Romania over the past 20 years – a sharper decrease than anywhere else in the world – and how rates have increased as a result. “We started from a pretty good coverage, but we’re now very low according to WHO standards and well below the level recommended for herd immunity. That led to an outbreak of measles between 2016 and 2019, with more than 17,000 reported cases. There were also 64 deaths, all except one in unvaccinated children.”

 

Justified fears


Historically, there have been plenty of situations where opposition to being vaccinated is extremely easy to understand. “We have to be careful when we identify resistance or hesitancy, to what people are resistant about,” Bhattacharya says. He gives several examples in the context of the smallpox vaccine in India in the 1960s. “The rotary lancet equipment which was initially used for smallpox vaccination effectively inflicted an open wound which could become infected. The resistance in rural India was not to the vaccine itself but to the sepsis which could result from the vaccination process.”

 

Later on, in the 1970s, vaccinating teams were feared for other reasons. “There was the occasion where 100 volunteers were trained to go into the villages of Uttar Pradesh. As it turned out all 100 were Hindu. They tried to vaccinate in Muslim-dominated villages, and they realised everyone had disappeared. This was also at the time when young Muslim men were being forcibly sterilised, and the later enquiry revealed that this was why they had run away. So very quickly international aid agencies learned that they needed to get a range of local collaborators, who could inform them about fears, and anger, and then slowly involve local vaccinators.”

 

There were some even more frightening incidents too. “International volunteers recruited to the Indian smallpox eradication programme were often heavily-built overseas workers over six feet tall. Their job was to hunt down people resisting vaccination, sit on them and forcibly vaccinate them. This is not a figment of my imagination; I actually interviewed the people who did the sitting and are now very guilty about having sat on emaciated bodies. And those emaciated bodies that were sat on so disrespectfully, those women who felt that their dignity had been compromised as they were sat on by a man, and their sari covering their faces was possibly moved, are now the bodies of grandmothers. They are some of the most influential decision-makers about vaccination out there.”

 

Larson has further examples of what she terms “the surrounding histories and politics that play out on vaccinations”. “We’ve seen multiple mass reactions to the HPV vaccine which have been deemed psychosomatic or anxiety-related in a number of settings. One very widely publicised case was in Colombia, where some of the girls were having cases of tachycardia, shortness of breath, chest pain and fainting. This was in an area with a history of paramilitary violence and sexual violence against young women. The experience of the vaccination triggered and released those deep anxieties and fears; and right now, if you go to any of the global registries, HPV has the absolute highest number of adverse events reported (not confirmed) following immunisation. There are a lot of reasons these anxieties are coming out – often unrelated to the vaccine itself, but triggered by the experience of vaccination.”

 

Parents’ concerns about vaccination


Even in ‘normal’ contemporary urban situations, vaccinating children, particularly new babies, can be a very upsetting experience. It involves, after all, putting a needle into a child and causing them pain. Particularly since this involves making an appointment, taking time off work, and possibly sorting quite a few other logistics too, it’s easy to see how hesitancy can tip over into reluctance, and then into avoidance without thinking through the genuine risk to a child who is not vaccinated. But importantly, Larson does not feel that vaccine hesitancy should simply be overruled. 

 

“We can't prevent vaccine hesitancy, and nor should we,” she says. “I mean, think about the whole process of smallpox variolation from the beginning: you take some virus from a cow and you put it in a child. That can’t be something nobody questions. Any responsible parent with a first-time child should be asking questions about what they're giving their child, whether it's a medicine or a vaccine or anything. So, the last thing we should be doing is shutting them up. In fact, that’s one of the biggest reasons we're having the challenges we face right now; I think it’s payback time for the years of ‘take this, it's good for you, it's totally safe, don't worry about it’.” 

 

In fact, Butler argues, many parents who do vaccinate are not particularly thinking their decision through either. “A lot of people vaccinate without thinking about it. Their decisions are neither well-informed nor poorly-informed; they are just doing it because of social copying.” “It’s very interesting that in Romania, the most vaccine-hesitant people are the ones who are highly educated and urban,” adds Mixich. Butler’s own experience echoes this too. “It’s truly remarkable, but there is a lot of vaccine hesitancy in families from higher socioeconomic groups where both parents work, particularly in northern Europe. The most fortunate often make the most unfortunate decisions. My own GP told me I’m in the hard-to-reach population. My wife and I both work, we don’t have a particularly cohesive relationship with our local community and we don’t go to church – so we become hard for health services to reach.”

 

But clearly, respecting this hesitancy does not mean accepting vaccine refusal. Instead, it’s important to analyse just what is going on, and particularly how vaccination hesitancy is able to spread at the moment; and, as a result, work out how it can be combated.

 

Trust and lack of trust


Larson argues very strongly that effective vaccination coverage only happens if people trust what is on offer. “Trust is about a relationship. Do we trust that someone is capable of doing what they say they can? And what is their motive? ”"Is this doctor genuinely concerned about the health of my child and my family, or is he/she in it for the money they make out of it?” some parents ask.

 

They need to trust the product, the healthcare system and the political system. Romania provides a very good example of a society where this is not the case, with inevitable results. “There is very low trust in the whole political infrastructure, including its institutions,” Mixich explains. “And the trust in the healthcare system is also extremely low, although we do place a reasonable amount of trust in scientists. A recent study also showed that Romanian parents, whether they’re vaccine-hesitant or not, have strong concerns about conflicts of interest and financial interest when it comes to doctors and the pharmaceutical industry.”

 

There’s an obvious further breakdown in trust if healthcare workers themselves express concern about the vaccine, as, for instance, a high proportion in Romania do. “There are a number of physicians in Armenia who actually state that they refused to vaccinate their children against anything except polio,” adds Crape. “They know the history of polio and what polio does, but they don't recognise the importance of vaccinations against all these other childhood diseases.” Overall, Larson sums this up as “one of the biggest challenges we have now. We have this whole cohort of health professionals including scientists and Nobel Prize winners who are questioning one or more vaccines”. 

 

 

The internet and fake news


The huge difference for the anti-vaccination movement and vaccine hesitancy has, of course, been the internet. In the past two decades, the way people consume, create and relay news has changed completely, with increasing numbers relying solely on what they find online – especially for health information. It is also, importantly, a worldwide change; people in extremely remote areas have access to the internet and all it contains – and the technology and platforms are also changing very rapidly.

 

The information online includes rigorous, peer-reviewed studies and meta-studies into different forms of immunisation. It also includes misinformation, misinterpretation and anecdotes presented as disinterested research – complete with pictures and video to give the messages extra punch. Crape cites examples in a range of different languages. “There’s a picture of crying baby and an ugly needle – it’s an emotionally laden photograph – alongside six reasons to say no to the vaccine. They’ll say that pharmaceutical companies can’t ever be trusted; that all vaccines are loaded with chemicals and heavy metals (in reality there are no heavy metals in the current children’s vaccines); and so on. Yes, a handful of vaccines have been removed from the market but those are very few and the ones that are currently provided are safe. And they say, ‘you can always get vaccinated, but you can never undo a vaccination’, to suggest that you still have the choice even if you don’t do it.” 

 

Crape adds: “This is all underpinned by bad or incomplete science or findings that are taken out of context. If you look at the peer-reviewed published literature, you can’t find evidence for the claims that rates of learning disabilities, or attention deficit hyperactivity disorder (ADHD) or autism are higher in children who have had the vaccines. And then finally they try to justify it further by showing books that show the dangers of vaccines, all of which are written by physicians, in order to show that this is real science, it’s a very serious problem and we're killing our children with vaccines. It doesn’t matter where you live: all you have to is pull out your phone and hook up to Google and they're all there for you. The anti-vaccination movement is spreading out from high-income countries and those countries haven’t responded sufficiently.” 

 

Public health campaigns and professional responses


Others agree that public health campaigns to date have not tended to dent the success of the anti-vaccination ones. “From a public health authority perspective there's not enough done in terms of understanding and managing Dr Google,” says Butler. “In Europe, reliable robust information that’s simply easy to use information usually comes at around 15th place on a search. I feel there’s not been enough done on it, but it’s also extremely difficult to tackle because a health authority can never be as nimble as a vocal single individual.”  

 

He adds: “As human beings, we’re guided by emotion, and we have a simplification bias. We find that when information and actions are easy to understand we're more likely to change our perceptions and behaviours accordingly. The anti-vaccine lobby understands this very well – and to some extent so do pro-vaccination campaigns, with examples like children blinded by rubella, so parents are often left with very mixed messages.” And most people decide in advance which stories they are going to believe, too. “We have a confirmation bias; we're more likely to believe messages that support the conclusions that we've already come to, and we filter new information according to this.” 

 

Dr Lynda Dunlop, Lecturer in the Department of Education at the University of York, adds a further perspective. “According to the WHO, around half the adults around Europe have poor health literacy. This goes right back to the classroom and how young people learn about science and health. We need better collaboration with teachers, research-informed resources, and support from other disciplines – and we need to pay attention to the values and attitudes that young people bring to the classroom in the first place.”

 

Larson also picks up the issue of how individual health professionals are not equipped to counter vaccine-hesitant patients or parents. “There’s usually very little in medical training about vaccines. You’re taught about giving a difficult diagnosis, but not about how to handle a conversation where someone says ‘I don’t want what you think I should have’ or start challenging you, which is happening more and more. Very often health professionals just shut down and say ‘That’s OK, you don’t have to have the vaccine’, in order to keep the trust of the patient. So, some groups are suggesting that training in dealing with that sort of conversation would be useful.”

 

Stories and narratives


Mixich frames this in terms of narratives and stories. “We are impressed by stories, regardless of how truthful those are or how well-prepared we are to appreciate them. They can be a good tool or a very dangerous one.” The anti-vaccination stories are often very coherent, moving and aimed at getting an emotional response: they are not concerned with the qualifications or nuances of factual reporting, because they operate on a different level. They also focus heavily on temporal associations – events that happen after vaccination but aren’t necessarily anything to do with the effects of vaccination.

 

“We are slowly understanding how to communicate better,” says Butler. “We’re realising that it’s not enough to ‘myth-bust’; we now know that it's very important that we replace that myth with information. And the way we frame our arguments and facts is very important as well, which unfortunately many healthcare practitioners in the European region still don't understand. You’re much more likely to opt for a burger that is 75 per cent fat-free, or a vaccine that is 99.9 per cent safe, than one that’s communicated to you in a different way.”

 

His feeling, though, is that vaccine hesitancy cannot be solved by communications alone. “Communications have a phenomenal amount to do with it, but we know from the last four decades of communicable disease prevention that knowledge doesn't necessarily predict action. An informed individual is not necessarily a behavioural responsive or responsible one. I think we need to embrace the social sciences, and people from medical humanities and medical anthropology backgrounds, to get their insights into hesitancy and what we need to do to tackle it. The solutions are as much to do with tailoring service provision as they are with communicating messages.”

 

“The end message is that evidence-based information isn’t enough any more,” Mixich concludes. “In countries like Romania, it’s very important for us to know that a safe and effective vaccine has two ingredients: good science and good stories.”

 

 

Radhika Holmström is a Wellcome Trust-funded writer and communications specialist working with the WHO Global Health Histories project at the University of York. 

 

Monday, 12 October 2020

Eradicating Polio

The WHO Collaborating Centre for Global Health Histories, supported by the Wellcome Trust, has produced a series of seminars in association with the WHO HQ, WHO Regional Offices, WHO Country Offices and national governments.  

One seminar, shown at a major WHO EURO event, focuses on the move towards world eradication of poliomyelitis and why this has still not been achieved, 20 years after the originally stated goal of 2000.

 

The seminar can be viewed and/or listened to here:


Global Health Histories Seminar 110: Polio, immunization and universal health coverage, University of York

Speaker(s): Thomas Abraham (Director, Public Health Communication Programme, Journalism and Media Studies Centre, the University of Hong Kong) and David Heymann (London School of Hygiene and Tropical Medicine, and Head of the Centre on Global Health Security at Chatham House & formerly WHO Assistant Director-General)

 

 

This briefing draws on the presentations at that seminar.

 

On 25 August 2020, the Africa Regional Certification Commission certified the WHO African Region as wild polio-free, after four years with no cases of wild poliomyelitis (polio) in the region. Over 90 per cent of the world’s population is now free of wild poliovirus, and only 33 cases were reported in 2018. However, Africa still faces the challenge of vaccine-derived polio, which as of October 2020 was present in 14 countries of the region.

 

Many people consider that polio eradication would constitute a major advance. There are three strains of wild poliovirus, each of which requires a specific vaccine to be eradicated and all of which cause paralysis. The disease mainly affects children, with roughly one in 200 wild poliovirus infections leading to irreversible paralysis. This is most often in the legs, but the brain and/or the breathing muscles can also be affected. At the same time, the majority of infected children are asymptomatic. “Whereas smallpox, for instance, is very easy to identify because it leaves pockmarks all over the body, for every child who is paralysed by polio there are 600 to 1,000 children who are infected and can transmit the disease to others but who show no signs whatsoever,” explains David Heymann (Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine, head of the Centre on Global Health Security at Chatham House and formerly WHO Assistant Director-General, with responsibility for polio eradication).  

 

In 1988, the World Health Assembly (WHA) passed a resolution to eradicate polio globally by 2000, describing this as ‘an appropriate gift … from the twentieth to the twenty-first century’. Type 2 was eradicated in 1999 and no case of type 3 has been found since the last reported case in Nigeria in November 2012. However, more than 20 years after the start of this century there is still endemic transmission of type 1 wild poliovirus in border areas of Afghanistan and Pakistan, and the WHO estimates that failing to eradicate polio from these areas could mean that polio spreads again, causing up to 200,000 new cases a year worldwide within 10 years.

 

“The polio programme itself is, as ever, optimistic. The message is that the incidence of polio has been reduced by 99 per cent from the time the programme was launched, and that is absolutely true,” says Thomas Abraham (Director, Public Health Communication Programme, Journalism and Media Studies Centre, the University of Hong Kong and author of Polio: The Odyssey of Eradication. “But in two countries it has not been interrupted, and at the same time vaccine-derived polio cases are repeatedly popping up in areas that were once thought to be polio-free.”

 

 

A sudden WHO priority


Abraham is particularly interested in how the decision by the WHA to eradicate the disease came about in. “On one level it's as clear as daylight: 1988 the World Health Assembly voted to try and eradicate polio by the year 2000, at another level it is really mysterious.”

 

The proposal to eradicate was made by WHO Director-General Dr Halfdan Mahler, only three weeks before his departure from the post, in a speech to the World Health Assembly in1988. The occasion was the 40th anniversary year of the WHO and the 10th anniversary of the declaration from the Alma-Ata International Conference on Primary Health Care, which had expressed ‘the need for urgent national and international action to protect and promote the health of all’.

 

However, Abraham points out, this was a quite surprising focus for Mahler, who had said publicly and repeatedly that the smallpox eradication programme was the last single-disease eradication programme to which the WHO would commit its resources. “His philosophy was completely different; that same money, he felt, was much better spent by building up health systems, especially at the village level. He firmly believed that the decision on which diseases ought to be tackled first was something that really should be determined at the levels of communities and not by big organisations sitting in Geneva or New York. For him, eradication programmes represented everything that was wrong with healthcare.” 

 

Yet suddenly, Mahler made a quite unexpected public commitment to eradicating polio within the next 12 years. “It was not even on the agenda initially. One of the most consequential decisions that the World Health Organization has taken was actually done pretty hastily – and it was also a really low-key resolution, saying that countries were ‘invited to formulate and consider plans for vaccination coverage in order to make this happen’. “There’s no paper trail to explain how this change happened, and the decision was hastily taken” This was in sharp contrast to the activity that preceded (and indeed succeeded) the resolution to eradicate smallpox.” 

 

Heymann offers another reason for Mahler’s change of mind. The Global Polio Eradication Initiative is a public-private partnership led by national governments with six-core partners – the WHO, Rotary International, the US Centers for Disease Control and Prevention, UNICEF, the Bill & Melinda Gates Foundation and Gavi, the Vaccine Alliance. Rotary International has been a particular driver in this. “Some of the Rotary groups from the US went to the Philippines back in the mid-1980s on an exchange programme, where they saw children paralysed from polio which had been gone from the US for almost 20 years. They became great advocates for getting rid of polio – they actually went over and helped in the vaccination programmes – and it was Rotary International which really pulled together a partnership with UNICEF, the WHO and the Center for Disease Control to tackle it. I would think it was Rotary that convinced Mahler that this was an important thing to do.” 

 

Immunisation and wider strategies


The polio eradication programme was linked to the WHO’s wider immunisation programme, which aimed to ensure that by 1990 every child would be immunised against diphtheria, pertussis (whooping cough) and tetanus. “The resolution said it should be pursued in ways to strengthen this integrated immunisation programme,” Heymann explains. “Polio was meant to be the sail if you like, and the wind hitting these sails would push the entire boat to shore,” Abraham adds. It was also an easy vaccine to deliver (unlike, for instance, smallpox vaccine) because it was given in oral drops and did not require trained health care workers to immunise children.

 

However, at the start of the programme access to polio vaccine varied hugely. In some richer countries it was offered routinely to children; conversely, in a number of WHO regions (Africa, the eastern Mediterranean and Southeast Asia) polio immunisation rates were far too low to produce herd immunity (which requires around 90 to 95 per cent immunisation). In addition to routine immunisation, the programme supported national immunisation campaigns to increase coverage. 

 

The other strategy in the eradication programme was a highly sophisticated surveillance programme using cutting-edge technology. A network of national and regional laboratories around the world took poliovirus isolated from stool specimens – including specimens taken from the Mumbai sewers – analysed them using genetic sequencing and stored the results in a shared global database. “That sequencing is very important because the poliovirus mutates at a steady rate as it transmits through humans and each type has many sub-families as a result,” says Heymann. “Genetic analysis means it’s easy not only to see what those mutations are but to trace back to see where the virus might have originated. For instance, in Pakistan they were actually able to find cases of polio in 2010 that could be linked back to cases in 2009 genetically; and that meant it was possible to go back to the place where this virus was thought to originate and make sure that it had indeed been eliminated from that area.”

 

Vaccine-derived polio


There is a further issue in that the oral form of polio vaccine contains a weakened form of the live poliovirus, which is excreted from the body. In places which do not have adequate sanitation this virus can spread to other people, and in areas where there is not a high enough immunity in the local population, the virus circulates and can mutate into a new active strain: a circulating vaccine-derived virus (cVDPV). 

 

As a result, in addition to the wild poliovirus still in circulation, cVDPV has become a major stumbling-block in the journey towards eradicating the disease. “In fact, now cases of vaccine-derived polio are greater than the number of wild polioviruses,” Abraham points out. “I think this is really worrying.”


Vaccination opposition


However, many vaccines have met with considerable opposition and polio is no exception. In 2003 wild polio had been absent from the state of Kano in northern Nigeria for four years when the state governor announced that he had read online that the vaccine made young girls sterile. “He saw this as a plot being run through the UN agencies which were controlled by Western countries,” says Heymann. “As a result, polio spread from Nigeria all the way across into Indonesia, through trade and religious pilgrimage groups. So, countries that had been polio-free became infected again. It was very hard to get polio activities restarted in northern Nigeria.”

 

Two laboratories, based in South Africa and India, which worked with the WHO – but crucially were not part of the WHO, as the WHO was considered part of the problem – offered to test the vaccine for the government of Nigeria. Their results showed no impurities which might cause sterility, but the Nigerian national vaccine expert group refused to accept this. A resolution from the Organisation of the Islamic Conference (now the Organisation of Islamic Cooperation), high-profile vaccinations and requirements from Saudi Arabia that all pilgrims entering the country were vaccinated all failed to change the governor’s views. Finally, a resolution from the WHO in 2008 and the subsequent pressure from within Nigeria did push him to rescind his views, but vaccine refusal continued for some time. 


Priorities, context and the future


Abraham also highlights another problem; that for many people, polio simply isn’t as important a priority as other conditions. He cites a man he met in northern Nigeria, who agreed to have his children vaccinated against polio. “Then he burst out later saying: ‘Polio, polio, polio. Why polio? When my child has a fever, the nearest public health centre is 10 kilometres down the road; I need to go to the main road and find a lift or a bus or get someone to take me there. When I get there, there are no medicines. But people are coming here every day and pressing polio drops on me.’ Children are dying of other things – malaria, measles, diarrheal diseases. These are the real killers, for many people, but they just see all the emphasis on polio, and it doesn’t make sense to them.”

 

Despite this, however, wild polio is nearly eradicated. Heymann flags up final concerns. “Strong leadership and innovation have been instrumental in stopping wild poliovirus. Countries have successfully coordinated their efforts to overcome major challenges such as high levels of population movement, conflict and insecurity restricting access to health services, and the virus’s ability to spread quickly and travel across borders. But the polio endgame has been slowed by vaccine-derived polio; we now have a world where vaccine-derived polio is equally as important as wild poliovirus.” 

 

What’s more, there is a considerable amount of the virus – both wild and polio-derived – either taken from the vaccine or from stool samples, which is still stored in laboratories around the world. “And there is one last sobering issue about polio eradication,” Heymann concludes. “Even after wild poliovirus is gone and vaccine-derived poliovirus is gone and all the poliovirus in these laboratories has been locked up or destroyed there will still be a risk because the poliovirus has actually been synthesised in a laboratory way back in 1991, just using the genetic sequence. It will still be possible to construct a new poliovirus. So, polio has had many challenges: and the final challenge is both when will eradication finally be completed and whether the disease will remain permanently eradicated.” 

 

Radhika Holmström is a Wellcome Trust-funded writer and communications specialist working with the WHO Global Health Histories project at the University of York.